Wealth Enhancement Advisory Services’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$592K Sell
8,873
-1,109
-11% -$70.5K ﹤0.01% 2182
2025
Q4
$645K Buy
9,982
+126
+1% +$7.84K ﹤0.01% 2285
2025
Q3
$593K Buy
9,856
+1,380
+16% +$56.9K ﹤0.01% 2225
2025
Q2
$294K Buy
8,476
+1,988
+31% +$69.1K ﹤0.01% 2660
2025
Q1
$261K Sell
6,488
-168
-3% -$7.72K ﹤0.01% 2551
2024
Q4
$313K Sell
6,656
-2,774
-29% -$144K ﹤0.01% 2349
2024
Q3
$498K Sell
9,430
-1,653
-15% -$92.1K ﹤0.01% 1837
2024
Q2
$600K Sell
11,083
-510
-4% -$30.8K ﹤0.01% 1534
2024
Q1
$813K Buy
+11,593
New +$897K ﹤0.01% 1331

Other funds holding CYTK